Review on Nanoparticle-Based Creams: Formulation, Characterization, and Applications in Therapeutics

Abstract

Nanoparticle-based creams have emerged as a promising advancement in the field of pharmaceutical and cosmetic formulations due to their ability to enhance drug delivery, improve skin penetration, and provide sustained release of active ingredients. This review explores the formulation strategies, characterization techniques, and therapeutic applications of nanoparticle creams. Various types of nanoparticles, including liposomes, solid lipid nanoparticles (SLNs), and polymeric nanoparticles, are discussed in terms of their advantages, challenges, and suitability for topical application. Additionally, the review delves into the mechanisms by which nanoparticles enhance the bioavailability and efficacy of active compounds, with a focus on dermatological applications such as wound healing, anti-aging, and drug delivery for skin diseases. Finally, future perspectives on the development of nanoparticle creams are presented, highlighting the need for innovation in formulation strategies, clinical testing, and regulatory standards.

Keywords

Introduction

The development of nanoparticle-based creams has revolutionized the field of topical drug delivery and cosmetic formulations. Nanoparticles are defined as materials with sizes ranging from 1 to 1000 nanometers, which exhibit unique physicochemical properties compared to bulk materials due to their small size, high surface area, and ability to interact with biological systems at the cellular level [1-3]. These properties enable nanoparticles to penetrate the skin barrier more efficiently, deliver active compounds at a controlled rate, and enhance therapeutic effects. In the context of topical drug delivery, nanoparticle creams offer several advantages over traditional formulations. They enable the encapsulation of a wide range of hydrophobic and hydrophilic drugs, protect sensitive compounds from degradation, and facilitate targeted delivery to specific skin layers. Additionally, nanoparticles can be designed to release their active ingredients in a sustained and controlled manner, reducing the frequency of application and improving patient compliance. This review aims to provide an in-depth analysis of nanoparticle creams, focusing on their formulation, characterization, and applications in therapeutics. The following sections discuss the types of nanoparticles used in topical creams, their methods of synthesis, their ability to enhance the efficacy of topical treatments, and their clinical applications [4-8].

2. Types of Nanoparticles Used in Topical Creams

Nanoparticles used in topical creams can be classified based on their composition, size, structure, and method of preparation. The most commonly used types of nanoparticles in creams include liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), polymeric nanoparticles, and metallic nanoparticles. Each type has unique characteristics that make it suitable for different therapeutic applications [9].

2.1 Liposomes

Liposomes are spherical vesicles composed of lipid bilayers that can encapsulate both hydrophilic and hydrophobic drugs. Due to their biocompatibility, ability to protect drugs from degradation, and potential for controlled release, liposomes have been extensively used in topical drug delivery. Liposome-based creams are particularly effective for the delivery of anti-inflammatory, analgesic, and antimicrobial agents to the skin. They can enhance the stability and efficacy of sensitive compounds like proteins, peptides, and small molecules by protecting them from oxidation and hydrolysis [10].

2.2 Solid Lipid Nanoparticles (SLNs)

SLNs are made from solid lipids that are stabilized by surfactants to form nanoparticles with a size range of 50-1000 nm. These nanoparticles can encapsulate both lipophilic and hydrophilic drugs, offering advantages such as improved drug solubility, enhanced skin penetration, and controlled drug release. SLN-based creams are commonly used for the delivery of anti-aging agents, sunscreens, and drugs for skin infections. They are also considered safe for topical applications due to their biocompatibility and non-toxic nature [11-12].

2.3 Nanostructured Lipid Carriers (NLCs)

NLCs are a second generation of lipid-based nanoparticles that are composed of a mixture of solid and liquid lipids. NLCs offer several advantages over SLNs, including improved stability, higher drug loading capacity, and the ability to release active ingredients in a sustained manner. NLC-based creams are particularly effective for delivering poorly water-soluble drugs to the skin and can be used in cosmetic formulations to improve skin hydration, reduce wrinkles, and protect against UV damage [13].

2.4 Polymeric Nanoparticles

Polymeric nanoparticles are composed of biocompatible polymers such as poly (lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), and chitosan. These nanoparticles can be engineered to have various sizes, surface charges, and functional groups, which influence their drug-loading capacity, release profile, and interaction with the skin. Polymeric nanoparticles are particularly useful for the sustained release of drugs and the targeted delivery of bioactive agents to specific layers of the skin. They are widely used in the treatment of dermatological conditions such as acne, psoriasis, and eczema [14].

2.5 Metallic Nanoparticles

Metallic nanoparticles, including silver, gold, and copper nanoparticles, are gaining interest for their unique antimicrobial properties and potential to enhance wound healing. These nanoparticles can be incorporated into topical creams to treat skin infections, promote tissue regeneration, and accelerate wound closure. Silver nanoparticles, in particular, are well-known for their broad-spectrum antimicrobial activity, making them a common component of creams used for wound care and burn treatment [15-16].

3. Formulation Strategies for Nanoparticle Creams [17-20]

The formulation of nanoparticle-based creams requires the careful selection of excipients and manufacturing processes to ensure the stability, efficacy, and safety of the product. Several factors influence the formulation of nanoparticle creams, including the type of nanoparticles, the active ingredients to be delivered, the desired release profile, and the compatibility of the nanoparticles with the cream base.

3.1 Excipients

Excipients play a crucial role in the formulation of nanoparticle creams. They help stabilize the nanoparticles, improve skin penetration, and enhance the release of active ingredients. Common excipients used in nanoparticle creams include emulsifiers, surfactants, humectants, preservatives, and thickeners. The selection of excipients must be made carefully to avoid interactions that could compromise the stability of the nanoparticles or cause skin irritation.

3.2 Manufacturing Processes

The manufacturing process for nanoparticle creams involves the dispersion of nanoparticles in a cream base. Methods such as high-pressure homogenization, solvent evaporation, and microemulsion techniques are commonly used to prepare nanoparticle creams. The choice of manufacturing process depends on the type of nanoparticles being used, the desired particle size, and the viscosity of the cream. High-pressure homogenization is one of the most widely used methods for the production of lipid-based nanoparticles and can produce nanoparticles with a narrow size distribution. Solvent evaporation techniques are commonly used for polymeric nanoparticles, while microemulsion-based methods are used for the production of liposomal creams.

3.3 Stability and Storage

Stability is a critical factor in the formulation of nanoparticle creams. The nanoparticles must remain stable over time, without aggregation or degradation, to ensure the efficacy and safety of the cream. Factors such as temperature, light exposure, and pH can affect the stability of nanoparticle formulations. The storage conditions and packaging materials must be optimized to prevent nanoparticle aggregation and ensure long-term stability [21].

4. Characterization of Nanoparticle Creams [22-25]

The characterization of nanoparticle creams is essential to assess their quality, performance, and safety. Several techniques are employed to evaluate the physical and chemical properties of nanoparticle-based creams, including particle size, morphology, zeta potential, drug loading, and release profile.

4.1 Particle Size and Morphology

The particle size and morphology of nanoparticles play a crucial role in determining the performance of nanoparticle creams. Smaller nanoparticles have better skin penetration and enhanced bioavailability, while larger nanoparticles may have limited skin permeability. Techniques such as dynamic light scattering (DLS), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) are commonly used to determine the size and morphology of nanoparticles in cream formulations.

4.2 Zeta Potential

The zeta potential of nanoparticles indicates their surface charge and stability in suspension. A high zeta potential (either positive or negative) ensures that the nanoparticles are well-dispersed and prevents aggregation. Zeta potential measurements can be used to optimize the formulation of nanoparticle creams and ensure that the nanoparticles remain stable over time.

4.3 Drug Loading and Encapsulation Efficiency

The drug loading capacity and encapsulation efficiency are important parameters in the formulation of nanoparticle creams. These factors determine how much of the active ingredient is incorporated into the nanoparticles and how effectively it is delivered to the skin. Techniques such as high-performance liquid chromatography (HPLC) and ultraviolet-visible (UV-Vis) spectroscopy are used to quantify the drug content in nanoparticle creams.

4.4 Release Profile

The release profile of active ingredients from nanoparticle creams determines how quickly and efficiently the drug is delivered to the skin. Controlled release is desirable for sustained therapeutic effects. In vitro release studies using Franz diffusion cells are commonly employed to evaluate the release kinetics of drugs from nanoparticle creams.

5. Applications of Nanoparticle Creams [26-28]

Nanoparticle creams have a wide range of applications in therapeutics and cosmetics due to their ability to enhance the delivery and effectiveness of active ingredients.

5.1 Dermatological Applications

Nanoparticle creams have been used for the treatment of various skin disorders, including acne, eczema, psoriasis, and dermatitis. The nanoparticles can effectively deliver anti-inflammatory, antibacterial, and antifungal agents to the skin, improving the efficacy of treatment while reducing side effects. For example, liposomal creams containing benzoyl peroxide or salicylic acid are commonly used for acne treatment.

5.2 Wound Healing and Tissue Regeneration

Nanoparticle creams containing silver, gold, or copper nanoparticles have shown promising results in promoting wound healing and tissue regeneration. These nanoparticles possess antimicrobial properties that prevent infection while stimulating tissue repair and collagen formation. They are commonly used in burn creams and dressings for wound care.

5.3 Cosmetic Applications

In cosmetics, nanoparticle creams are used to deliver anti-aging agents, moisturizers, sunscreens, and skin brightening compounds. Nanoparticles such as nanostructured lipid carriers (NLCs) and liposomes can encapsulate hydrophilic and lipophilic active ingredients, improving their stability, skin penetration, and efficacy.

CONCLUSION AND FUTURE PERSPECTIVES

Nanoparticle-based creams represent a significant advancement in topical drug delivery systems, offering enhanced skin penetration, controlled release, and improved therapeutic efficacy. Liposomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, and metallic nanoparticles each have distinct advantages, making them suitable for a wide range of therapeutic and cosmetic applications. However, challenges remain in terms of optimizing formulations, ensuring long-term stability, and meeting regulatory requirements for safety and efficacy. Future research will likely focus on improving the formulation and characterization techniques, as well as exploring new types of nanoparticles and delivery systems for targeted therapies. The continued development of nanoparticle creams promises to enhance the treatment of skin diseases, wound healing, and cosmetic skin care, paving the way for more effective and personalized treatment options.

REFERENCES

1. Gao L, Zang D, Chen M (2008) Drug Nanocrystal for Formulation of Poorly Soluble Drug and Its Application as Potecial Drug Delivery System. J Nano Part Res 10(1): 845-862.
2. Peltonen L, Hirvonen J (2018) Drug Nanocrystal Versatile Option for Formulation of Poorly Soluble Material. International Journal of Pharmaceutics 537(1-2): 73-83.
3. Nagarajan R (2008) Nanoparticles: Building Blocks for Nanotechnology. American Chemical Society pp: 2-14.
4. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, et al. (2012) Nanotechnology in Therapeutics: A Focus on Nanoparticles as a Drug Delivery System. Nanomedicine 7(8): 1253-1271.
5. Junyaprasert VB, Morakul B (2015) Nanocrystal for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs. Asian journal of Pharmaceutical Science 10(1): 13-23.
6. Lee BK, Yun YH, Park K (2015) Smart nanoparticles for drug delivery: Boundaries and Opportunities. Chemical Engineering Science 125(1): 158-164.
7. Ravichdran R (2009) nanotechnology-based drug delivery system. Nanobiotechnol 5(1): 17-33.
8. Sivasankar M, Kumar BP (2010) Role of Nanoparticles in Drug Delivery System. International Journal of Research in Pharmaceutical and Biomedical Sciences.
9. Boyd RD, Pichaimuthu SK, Cuenat A (2011) Colloid and surfaces A: Physicochemical and engineering aspects. Elsevier journal pp: 38735-38742.
10. Liang YC, Binner JGP (2008) Effect of Triblock Copolymer non-ionic surfactant on The Rheology of 3 mol % Stabilized Zirconia Nanoparticles. Ceram Int 34(2): 293- 297.
11. Muller RH, Jacobs C (2002b) Production and Characterization of a Budesonide Nanoparticle for Pulmonary Administration. Pharm Res 19(1): 189-194.
12. Moshrra MN (1995) The Effect of Particle Size and Shape on the Surface Specific Dissolution Rate of Insoluble Drugs. International Journal of Pharmaceutics 122(1-2): 35-47.
13. Shegokar R, Muller RH (2010) Nanocrystals: Industrially Feasible Multifunctional Formulation Technology for Poorly Soluble Actives. International Journal of Pharmaceutics 399(1): 129-139.
14. Qingguo XU, Kambhampati SP, Kannan RM (2013) Nanoparticle use in Ophthalmic Disease. Middle East African Journal Optalmol 20(1): 26-37.
15. Sun B, Yeo Y (2012) Nanocrystals for the Parenteral Delivery of Poorly water-soluble drugs. Current Opinion in Solid State and Materials Science 16(6): 295-301.
16. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, et al. (2008) Nanoparticles in Medicine: Therapeutic Applications and Developments. Clinical Pharmacology and Therapeutics 83(5): 761-769.
17. Pitaksuteepong T (2005) Nanoparticle: A Vaccine Adjuvant for Subcutaneous Administration. Naresuan University Journal 13(2): 53-62.
18. Shen WZ, Cetinel S, Sharma K, Borujeny ER, Montemagno C, et al. (2017) Peptide-functionalized iron oxide magnetic nanoparticle for gold mining. J Nanopart Res 19(2): 74.
19. Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y, et al. (2004) Quantum dots as photosensitizers? Nat Bioethanol 22(1): 1360-1361.
20. Feng X, Zhang S, Lou X (2013) Controlling silica coating thickness on TiO2 nanoparticles for effective photodynamic therapy. Colloids Surf B Bio interfaces 107(1): 220-226.
21. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, et al. (2013) Ceramic based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125(26): 7860-7865.
22. Lina W, Staytona I, Huangb Y, Zhouc X, Maa Y, et al. (2008) Cytotoxicity and cell membrane depolarization induced by aluminium oxide nanoparticles in human lung epithelial cells A549. Toxicol Env
23. Lina W, Staytona I, Huangb Y, Zhouc X, Maa Y, et al. (2008) Cytotoxicity and cell membrane depolarization induced by aluminium oxide nanoparticles in human lung epithelial cells A549. Toxicol Environ Chem 90(5): 983-996.
24. Till U, Gibot L, Vicendo P, Rols MP, Gauche M, et al. (2016) Crosslinked polymeric self-assemblies as an efficient strategy for photodynamic therapy on a 3D cell culture. RSC Adv 2016 6(74): 69984-69998.
25. Sailaja AK (2013) Formulation of magnetic nanoparticles and their applications. Innovare J Life Sci 1(3): 6-9.
26. Calero M, Chiappi M, Carrillo AL, Rodríguez MJ, Chichón FJ, et al. (2015) Characterization of interaction of magnetic nanoparticles with breast cancer cells. J Nanobiotechnol 13(1): 16.
27. Anselmo AC, Mitragotri S (2016) Nanoparticles in the clinic. Bioeng Transl Med 1(1): 10-29.